eli lilly retatrutide phase 3 trial 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide Phase 3: TRIUMPH Program

Chasing the elusive mammalian microautophagy

It is manufactured in an FDA-registered facility and meets NSF certification and GMP compliance standards

doi: 10.1210/endo-128-1-394

Mounjaro is a drug that works to promote the secretion of insulin, which is different from insulin injections

Candidates are typically individuals who: Struggle with weight loss despite diet and exercise Want support with appetite control and cravings Are seeking a medically supervised approach to wellness Meet provider eligibility guidelines after consultation All patients must complete a medical intake and consultation with a licensed provider prior to treatment

Consistent Strength Training: Muscle is the organ of longevity